How to Implement Risk Management Principles and Activities Within a Quality Management System

Nov. 03 & 04, 2008, The Park Plaza Wallstreet, Berlin, Germany
The Center for Professional Innovation & Education has designed this two-day course for quality managers, engineers, auditors, regulatory/quality compliance professionals, production managers and top management interested in learning the value of Risk Management Principals and how to enhance existing systems by better utilizing resources through the optimization of risk management techniques.

This program will provide a broad introduction to the subject of risk management for more experienced personnel, including middle and upper management. It will allow participants to update and broaden their knowledge of US and International Risk Management requirements. It explores both the positive and negative aspects of risk and aims to improve knowledge and practical skills in the identification assessment and control of business risk.

Upon completion of this course, attendees will understand how to effectively meet the requirements of risk management for medical devices, pharmaceutical and biologics products and processes. Emphasis will be placed on the effective use of resources in a production and quality system environment by developing strategies based on risk.

The first day will cover the general context for risk management, required procedures and the discussion of the general ISO 14971, FDA, and GHTF requirements of risk management. The second day will discuss and apply several risk management techniques which will be covered as they relate to product and production processes.

For further information and registration, please visit:
http://www.cfpie.com/showitem.aspx?productid=041&source=wpnc

About The Center for Professional Innovation & Education (CfPIE)
The Center for Professional Innovation & Education is the global leader in accredited pharmaceutical training including courses on Biotech, Biopharmaceutical, Medical Device and Skin/Cosmetic product topics. With over 270 public courses and customized client-site training programs offered annually, CfPIE has a convenient option for personnel looking for both professional advancement and technical/regulatory training.

Most Popular Now

Lilly will supply an additional 150,000 doses of b…

Eli Lilly and Company (NYSE: LLY) announced a modified purchase agreement with the U.S. government to supply an additional 150,000 doses of bebtelovimab for approximately...

Bayer to sell men's health product Nebido™ to Grün…

Bayer and Grünenthal have entered into a definitive agreement regarding the sale of Bayer's men's health product Nebido™ (testosterone undecanoate), for a purchase price ...

Pfizer and BioNTech complete submission to Europea…

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced they have completed a submission to the European Medicines Agency (EMA) for an Omicron-adapted biva...

The fourth COVID-19 vaccine reduces the risk of de…

A new study by Tel Aviv University and Ben Gurion University of the Negev, in collaboration with the Israeli Ministry of Health, has found that the fourth COVID-19 vaccin...

Vaccine protection against COVID-19 short-lived, b…

Since COVID-19 vaccines first became available to protect against infection and severe illness, there has been much uncertainty about how long the protection lasts, and w...

AstraZeneca to acquire TeneoTwo and its clinical-s…

AstraZeneca announced an agreement to acquire TeneoTwo, Inc. (TeneoTwo)i, including its Phase I clinical-stage CD19/CD3 T-cell engager, TNB-486, currently under evaluatio...

Demonstration of a potent, universal coronavirus m…

The SARS-CoV-2 that causes COVID-19 has killed 6.3 million people worldwide since 2019, painfully highlighting the vulnerability of humanity to novel coronaviruses. Re...

Research shows investigational drug fosters nerve …

Scientists from the University of Birmingham have shown that a brain-penetrating candidate drug currently in development as a cancer therapy can foster regeneration of da...

NIH launches clinical trial of mRNA Nipah virus va…

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has launched an early-stage clinical trial evaluating an inv...

Anti-inflammatory compound shows potential in trea…

An anti-inflammatory compound may have the potential to treat systemic inflammation and brain injury in patients with severe COVID-19 and significantly reduce their chanc...

Vaccine-induced immune response to omicron wanes s…

Although COVID-19 booster vaccinations in adults elicit high levels of neutralizing antibodies against the Omicron variant of SARS-CoV-2, antibody levels decrease substan...

SARS-CoV-2 hijacks nanotubes between neurons to in…

COVID-19 often leads to neurological symptoms, such as a loss of taste or smell, or cognitive impairments (including memory loss and concentration difficulties), both dur...